Patents by Inventor Michael John HUTCHINSON

Michael John HUTCHINSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE
    Publication number: 20230364013
    Abstract: The present disclosure is directed to oral dosage forms and processes for producing the oral dosage forms. The dosage forms include an Epinephrine hormone or pharmaceutically acceptable salt or solvate thereof, an antioxidant, and a chelating agent. The antioxidant can be sodium metabisulfate and the chelating agent can be edetate disodium (“EDTA”).
    Type: Application
    Filed: October 7, 2021
    Publication date: November 16, 2023
    Applicant: Catalent U.K. Swindon Zydis Limited
    Inventors: Leon Paul GROTHER, Nicholas Walker BARRAS, Philip AXE, Michael John HUTCHINSON
  • PHARMACEUTICAL COMPOSITIONS COMPRISING COATED API
    Publication number: 20220031610
    Abstract: Provided are pharmaceutical compositions and methods for preparing pharmaceutical compositions comprising coated API. Excess coating material that is not bound to coated API may be removed by a sieving process. Coating and dosing ratios can also be optimized to minimize the amount of excess unbound coating material. Additionally, the compositions can be formulated to preserve the functional coating of coated API and to minimize aeration of API when mixed into suspension.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Applicant: Catalent U.K. Swindon Zydis Limited
    Inventors: Rosaleen MCLAUGHLIN, Simon Andrew Martyn HOWES, Craig WHEADON, Jonathon WHITEHOUSE, Adam PARKER, Michael John HUTCHINSON